Vascular Access Device Market

The report "Vascular Access Device Market Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031" is projected to grow from USD 6.29 billion in 2026 to USD 8.70 billion by 2031, at a CAGR of 6.7% over the forecast period.

Browse 380 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on "Vascular Access Device Market, Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/vascular-access-device-market-122149686.html

The market is gaining momentum as the rising prevalence of chronic and lifestyle diseases, expanding chemotherapy and dialysis volumes, and a strong clinical emphasis on infection control drive demand for safer, more reliable vascular access. Healthcare providers are increasingly adopting safety-engineered catheters, antimicrobial- and antithrombogenic-coated devices, and ultrasound-guided insertion to reduce catheter-related bloodstream infections (CRBSIs) and needlestick injuries. At the same time, the shift of infusion therapy toward outpatient clinics and home healthcare is expanding the addressable patient pool. Manufacturers, including Becton Dickinson, Teleflex, and B. Braun, are broadening portfolios across peripheral, central, and intraosseous access to support value-based care and stricter regulatory standards.

By type, the peripheral vascular access device segment is expected to register the highest CAGR during the forecast period.

The peripheral vascular access device segment is expected to grow the fastest in the VAD market over the forecast period. Demand is rising primarily due to the increasing incidence of chronic conditions such as diabetes, cancer, and cardiovascular disorders, which require patients to undergo intravenous therapy, blood sampling, and medication delivery at regular intervals. Higher hospital admissions, emergency care volumes, and outpatient procedure counts further support the need for reliable short-term access. Advances in safety-engineered catheters, biocompatible materials, and designs that minimize infection and needlestick injuries are accelerating clinical adoption. In addition, the growth of ambulatory surgery centers, home healthcare, and value-based care models is increasing the popularity of peripheral access devices due to their ease of placement, low complication rates, and lower overall treatment costs.

By end user, the hospitals segment is estimated to hold the largest market share during the forecast period.

Hospitals were projected to dominate the vascular access device market in 2025. Hospitals manage the highest volumes of drug administration, fluid and nutrition delivery, blood transfusion, and diagnostic procedures, all of which depend on dependable vascular access. Because device insertion can carry complications such as infection, thrombosis, and malposition, procedures are often performed by trained clinicians and nurses supported by advanced imaging and ultrasound guidance available in hospital settings. Rising surgical volumes, expanding critical-care capacity, and government and institutional investments in hospital infrastructure continue to reinforce the segment's leading position.

North America is expected to lead the market during the forecast period.

North America holds the largest share of the vascular access device market, supported by a high burden of chronic disease, advanced healthcare infrastructure, strong adoption of safety-engineered and antimicrobial devices, and the presence of leading manufacturers. The region's large oncology, dialysis, and critical-care populations sustain high demand for both peripheral and central access. Favorable reimbursement, established group purchasing organization (GPO) frameworks, and stringent infection-prevention standards from agencies such as the FDA and CDC further accelerate the adoption of premium, infection-resistant devices. Asia Pacific is expected to register strong growth, driven by expanding hospital networks, a growing geriatric population, and rising healthcare investment across China, Japan, and India.

The major players in the vascular access device market include Becton, Dickinson and Company (US), Terumo Corporation (Japan), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), Merit Medical Systems, Inc. (US), Nipro Corporation (Japan), Vygon (France), AngioDynamics (US), Mozarc Medical Holding LLC (US), Spectrum Vascular (US), AMECATH (Egypt),  Medical Components, Inc. (Medcomp) (US), Healthline Medical Products (US), and Access Vascular, Inc. (US).

Don’t miss out on business opportunities in vascular access device market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com